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Objectives: The rate of contralateral prophylactic mastectomy (CPM)
has risen sharply in the past decade. The current study was designed to
examine social network, surgeon, and media influence on patients’
CPM decision-making, examining not only who influenced the deci-
sion, and to what extent, but also the type of influence exerted.
Methods: Patients (N = 113) who underwent CPM at 4 Indiana
University–affiliated hospitals between 2008 and 2012 completed
structured telephone interviews in 2013. Questions addressed the
involvement and influence of the social network (family, friends, and
nonsurgeon health professionals), surgeon, and media on the CPM
decision.
Results: Spouses, children, family, friends, and health professionals
were reported as exerting a meaningful degree of influence on patients’
decisions, largely in ways that were positive or neutral toward CPM.
Most surgeons were regarded as providing options rather than
encouraging or discouraging CPM. Media influence was present, but
limited.
Conclusions: Patients who choose CPM do so with influence and
support from members of their social networks. Reversing the
increasing choice of CPM will require educating these influential
others, which can be accomplished by encouraging patients to include
them in clinical consultations, and by providing patients with educa-
tional materials that can be shared with their social networks. Surgeons
need to be perceived as having an opinion, specifically that CPM
should be reserved for those patients for whom it is medically
indicated.
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The rate of contralateral prophylactic mastectomy (CPM)has risen sharply in the past decade.1–4 This increase has
been associated with a number of factors including patients’
perception that CPM improves survival (vs. unilateral mas-
tectomy).5 However, there has been no survival benefit from
CPM demonstrated in the absence of specific risk factors (eg, a
BRCA1/2 mutation),6–9 and the procedure is both more costly
than unilateral mastectomy10 and is associated with significant
increases in a subset of surgical site complications.11 Con-
sequently, expert medical recommendations, such as those
from the National Comprehensive Cancer Network, advise that
women with unilateral breast cancer should not undergo CPM
in the absence of factors that strongly increase breast cancer
risk (http://www.nccn.org/professionals/physician_gls/PDF/
breast.pdf, https://www.nccn.org/professionals/physician_gls/
pdf/breast_risk.pdf).
Indeed, research on predictors of CPM indicates that the
decade’s increase is patient driven rather than surgeon
driven.12–14 Large-scale studies of demographic factors dem-
onstrate that women are more likely to undergo CPM if they
are younger, more affluent, well insured, and white.15,16 Taken
together, these factors suggest a profile of CPM patients who
have the resources and competencies to successfully advocate
for procedures their physicians do not necessarily support. In
addition, a recent study found a 3-fold increase in CPM when
patients reported a “patient-driven decision” versus a
“physician-driven decision.”5
However, women with breast cancer are also wives,
mothers, daughters, sisters, and friends, and as such, their deci-
sions about breast cancer treatments are made in the context of
these relationships.17 Breast cancer patients often bring spouses,
friends, or children with them to medical visits18 and depend on
them for multiple forms of support,19 which can include partic-
ipation in decision-making.17,20 Women with breast cancer also
utilize traditional mass media, the Internet, and social media,
where they have a high likelihood of encountering information
about breast cancer, ranging from science news reports to stories
about celebrities with breast cancer.21–24
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To the extent that social network members and mass
media are significant influences on patient demand for CPM,
the medical community will need to address these influences if
the existing trend is to be halted and reversed. To date, several
authors have asserted that social network members affect
patients’ CPM choices,24 but there has been little systematic
attention to this influence. In perhaps the only study to date that
has assessed social network influence on CPM decisions, Soran
et al25 reported that 49% of the women in their study were
influenced by spouses or partners, 30% by friends and rela-
tives, and 25% by their mothers. Women in their study also
reported that 68% of spouses/partners were positive toward
CPM, as were 64% of friends and relatives. The current study
was designed to provide a more detailed analysis of social
network influence on CPM decision-making, examining not
only who influenced the decision-making, and to what extent,
but also the type of influence exerted.
MATERIALS AND METHODS
Ethics
This study was approved by the Indiana University
Institutional Review Board (IRB-04, protocol number
1210009689; and IRB-03, protocol number 1304011094). All
research was carried out in compliance with the Helsinki
Declaration.
Participants
Potential participants were identified from the Indiana
University, Wishard (now the Sidney and Lois Eskenazi
Hospital), IU Health North and IU Health West hospital billing
records using the procedure code for bilateral mastectomy
during the years 2008 to 2012. The lists were then curated to
identify patients who had undergone CPM (n = 326). The
patient’s name, address, telephone number, and hospital loca-
tion were obtained from the medical health record system.
These patients were mailed an introductory letter and study
information sheet, after which they were contacted by tele-
phone and a structured interview conducted with those who
agreed (n = 117). Only 16 patients contacted were recorded as
explicitly refusing the interview; no reasons were provided,
and information about these patients was not retained. Non-
participation of all others resulted from inability to reach
patients at the phone numbers in their records. Data were
collected in the summer and fall of 2013, so there was some
overlap between the period of data collection and media
attention given to Angelina Jolie’s prophylactic double mas-
tectomy (http://www.nytimes.com/2013/05/14/opinion/my-
medical-choice.html). However, all the surgical decisions were
made before 2013.
All participants were women (n = 117, 100%); 4 patients
self-identified as BRCA positive, and their data were removed
from analysis because this suggests that CPM was medically
indicated, changing the nature of the surgical decision-making
process. Participant demographics (n = 113) reflect participant
status at the time of the surgery. Participants were aged 22 to
73 (M= 50.29, SD= 12.50), predominately married (n = 86,
77%), employed (n = 73, 66%), and had private insurance
(n = 80, 71%). Participants identified as white (n = 99, 88%),
black (n = 12, 11%), and Hispanic (n = 2, 1.8%). Participants
varied by household income: <25K (n = 7, 6.20%), 26 to 50K
(n = 20, 17.7%), 51 to 75K (n = 25, 22.1%), 76 to 100K (n = 17,
15%), and >101K (n = 30, 10.6%). Participants reported vari-
ous degrees of education: high school or less (n = 22, 19.5%),
some college (n = 36, 31.9%), bachelor’s degree (n = 32,
28.3%), and graduate education (n = 21, 18.6%). Most women
reported diagnoses of invasive ductal cancer (n = 31, 26.5%),
ductal carcinoma in situ (n = 24, 20.5%), invasive cancer
(n = 27, 23.1%), and invasive lobular cancer (n = 9, 7.7%).
Most were diagnosed in 2008 to 2012. Four participants with
diagnosis dates before 2008 reported having had CPM after a
local recurrence.
Protocol
This analysis was part of a larger investigation of how
breast cancer patients select CPM. Participants initially
responded to items reporting their individual motivations for
undergoing CPM; analyses of these data are reported else-
where (Baptiste DF, MacGeorge EL, Venetis MK, Mouton A,
Friley LB, Pastor R, Hatten K, Lagoo J, Clare SE, and Bowling
MW. 2016; submitted for publication). Then, participants
were asked to identify everyone with whom they had talked
about what kind of surgery to have, including both social
network members and health care providers other than sur-
geons. For each member of the social network, participants
provided the relationship to the other (ie, friend, mother,
husband), the other’s history with breast cancer (with or
without history of breast cancer), the degree of influence
ranging from 0 (no influence) to 5 (great deal of influence), and
a free-response description of the type of influence exerted. For
each health care provider, participants provided the type of
relationship (eg, nurse practitioner, counselor), degree of
influence, and free-response description of influence. Partic-
ipants were then asked to describe the discussion they had with
the surgeon about the surgical decision, followed by 2 closed-
ended questions about whether the surgeon suggested CPM
and supported CPM. Finally, participants were asked whether
the media had played role in their decisions, and if so, to
describe that influence. The interview concluded with ques-
tions about race, education, employment, income, and
insurance.
On the basis of review of the data, 2 of the authors
(E.L.M. and M.K.V.) created coding categories for the types of
influence exerted by social network members and nonsurgeon
health care professionals. Definitions and examples are pro-
vided in Table 1. Similarly, coding categories were created for
the types of influence exerted by surgeons (Table 2). These
authors individually coded the data. Coding reliability between
authors was good (Krippendorff a= 0.77 for the 8 types of
network influence and 0.84 for the 4 types of surgeon influ-
ence). Discrepancies were resolved through discussion.
RESULTS
As shown in Table 3, nearly all participants reported
discussing their surgical options with at least 1 person other
than a surgeon; only 3 reported not talking with anyone. Many
reported talking with male spouses or partners, 1 or more
friends or family members who had experienced breast cancer,
and 1 or more friends or family members who had not expe-
rienced breast cancer. Smaller percentages reported talking
with health professionals, such as a medical oncologist, nurse,
therapist, or member of the clergy, and with children. Median
and modal values indicate that the “typical” participant talked
with 2 or 3 people about the surgical decision.
Also as shown in Table 3, most participants also reported
at that least one of the individuals they talked with influenced
the decision to some degree. Participants most frequently
reported as “influencers” their spouses, family, and friends
with a history of breast cancer, followed by health
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professionals, family, and friends without experience of breast
cancer, and children. As indicated by the median and modal
values, the “typical” participant’s decision was influenced by
2 people.
On average, spouses, children, family, friends, and health
professionals exerted a meaningful degree of influence, with a
mean of 3.2 (SD= 1.25) on a scale where 3 corresponds with
“some influence.” The greatest average influence was reported
from spouses/partners (M = 3.67, SD= 1.36) and children
(M= 3.65, SD= 1.32), followed by family and friends without
a history of breast cancer (M= 3.48, SD= 1.45), family and
friends with a history of breast cancer (M= 3.43, SD= 1.37),
and nonsurgeon health professionals (M= 2.95, SD= 1.41).
However, paired-samples t tests revealed that these mean dif-
ferences were not significant; P-values for all tests exceeded
0.05, indicating that the quantity of influence exerted by
individuals in these groups is not statistically different.
As shown in Table 4, there was variation in the type of
influence exerted by members of the social network. A 1-way
w2 test indicates that this variation is significant (w27 = 106.66,
P < 0.001). The most common type of influence was experi-
ential, in which a social network member had direct or indirect
experience with breast cancer that the participant reported as
influence. Although the details reported were diverse, most
responses in this category focused on cancer recurrence after
lumpectomy or a new contralateral primary after a single
mastectomy, family history of cancer, or (less commonly) on
satisfaction with CPM. Consequently, the experiential form of
influence consists largely of implicit support for CPM (from
the patient’s perspective). Moderately (and similarly) frequent
forms of influence were (in order of frequency) supporting the
patient’s choice, providing information, encouraging CPM
(explicitly), being generally supportive, and allowing the
patient to talk about the decision. Deciding together and dis-
couraging CPM were infrequent.
TABLE 1. Types of Influence
Type of
Influence Definition Example
Experiential Other had direct or indirect
experience with breast cancer that
participant reported as influence
Friend 1: had DCIS and underwent lumpectomy and radiation. With her anything that
could happen with the radiation happened, and her cancer has come back. I asked her
about whether I should do the double and she cried and said she wished she had done
that too
Talk Other engaged in conversation,
listened, and shared thoughts
Sister: There to process the information, like a sounding board. She came to the doctor’s
office with me for my appointments
Encouraged CPM Other actively promoted CPM Children: Entire immediate family (kids and husband) wanted me to do double
mastectomy, had big fear of it coming back, so I thought it was the best decision.
Made sure everyone got their feelings out, we talked it over as a family
Supported my
choice
Other was agreeable with decision
made by participant
Sisters: they were on board for whatever I wanted to do
Decided together Other discussed treatment options
and made the treatment with
participant (different from talk in
emphasis on joint decision-
making)
Husband: I really value his opinion, we discussed everything and decided together
Was supportive Other was supportive (no further
detail about influence)
Friend: She was just as supportive as my mom and dad. She took me on like I was her
daughter. She took me back and forth to my appointments, she went with me to my
treatments, to my appointments with my surgeon. She was very supportive and said
she would do whatever she had to do to see me through my surgery
Provided
information
Other helped participant to find or
understand information
Nurse: explained her diagnosis in layman’s terms. Talked to her extensively about the
pros and cons of her decisions
Discouraged CPM Other supported alternative surgical
options
Friend 3: Had breast cancer and underwent single mastectomy. She just thinks her way is
the best way so she was very supportive but not very helpful. So she was ok with my
choice, she had the same cancer surgeon, but she doesn’t understand why anybody
would do anything different from what she does about her cancer and she can’t let
people make their own decisions
TABLE 2. Surgeon Influence in Discussion of Surgery
Type of
Surgeon
Influence Example Frequency
Presented
options
The surgeon was pretty thorough in
going through different treatment
options and the pros and cons
74
Encouraged
CPM
She highly suggested that I have both of
them removed because I had it for 2
years and it was undetectable. If I
didn’t it could come back and I may
not know it. It was such a high risk that
I should remove them
8
Discouraged
CPM
yShe told me to think about it, consider
it over a short time, and if that’s what I
decided I wanted she would do it even
though that’s not what she would
personally recommendy
3
Other So happy I found her! She explained
everything really well. She didn’t rush
me. I thought she was a little
sentimental, sometimes a little too
much, but she’s very nice and not
abrasive. She’s good at what she does,
and it shows when she interacts with
her patients
23
Total 108*
*Five participants did not respond to this question, or were unable to recall
details of discussion with their surgeon.
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Different influence strategies were also more and less
frequent in different types of relationships. Discouraging CPM
and deciding together occurred too infrequently to be included
in a 2-way w2 analysis (they resulted in multiple cells with very
low expected frequencies). The number of influence attempts
reported from children was also too small to be treated as a
separate category, so influence by children was combined with
spouse/partner, as these relationships were both in the partic-
ipant’s nuclear family and their reported quantity of influence
was highly similar. The 2-way w2 assessing the frequency of
the 6 most frequent influence types in the 4 relationship types
indicated that the observed variation is significant
(w215 = 233.04, Cramer V= 0.557, P < 0.001). As shown
in Table 4, family and friends who had experienced breast
cancer were most frequently reported to exert experiential
influence, whereas health professionals typically provided
information. Spouses, children, and family or friends who had
not experienced breast cancer tended to use the remaining
influence types: talking, encouraging CPM, supporting the
patient’s choice, and being generally supportive.
As shown in Table 2, most participants described the
surgeon’s behavior during the discussion of surgery as pro-
viding options. Relatively few were reported to explicitly
encourage or discourage CPM. A 1-way w2 test indicates that
this variation is statistically significant (w23 = 117.11,
P < 0.001). However, somewhat more than half (N = 62,
54.9%) of participants reported that their surgeons suggested
CPM, whereas somewhat less than half (N = 49, 43.4%) said
their surgeons did not (2 participants did not answer this
question). Only 1 participant reported that the surgeon did not
support her choice of CPM; aside from the 2 who did not
answer, all other participants believed their surgeons supported
their choice.
A minority of participants (N = 31, 27.4%) reported some
degree of media influence on the decision to elect CPM.
Sources of reported influence included television (n = 12),
Internet (n = 11), radio (n = 2), and books (n = 6). Some par-
ticipants mentioned specific celebrities and authors such as
Christina Applegate, Suzanne Summers, Susan Love, and
Dianna Duberry (an Indianapolis news anchor). Others
TABLE 3. People Talked With and Influenced by
No. Participants
Who Talked With
Person of This
Type (n [%])
No. People They
Talked With
No. Participants Influenced
by Person of This
Type (n [%])
No. People They Were
Influenced by
Spouse/partner 75 (66.4) N/A 58 (48.7) N/A
Children 43 (38.1) Range: 1-2*
M= 1.16, SD= 0.37
Median = 1, mode = 1
17 (15) Range: 1-2*
M= 1.41, SD= 0.51
Median = 1, mode = 1
Friends/family—breast
cancerw
85 (75) Range: 1-8
M= 3.40, SD= 2.82
Median = 2, mode = 1
57 (50.4) Range: 1-5
M= 1.84, SD= 1.05
Median = 1, mode = 1
Friends/family—no
breast cancer
65 (57.5) Range: 1-6
M= 2.92, SD= 2.20
Median = 2, mode = 1
30 (26.5) Range: 1-2
M= 1.13, SD= 0.35
Median = 1, mode = 1
Health professionals 42 (37) Range: 1-7
M= 4.19, SD= 2.88
Median = 5, mode = 7
36 (31.8) Range: 1-3
M= 1.25, SD= 0.50
Median = 1, mode = 1
Any 110 (96.5) Range: 1-23*
M= 6.9, SD= 7.93
Median = 3, mode = 2
99 (87.6) Range: 1-8*
M= 2.7, SD= 1.67
Median = 2, mode = 2
*Values reported in this cell may slightly underestimate of children talked with or influencing decision, as some interviewers did not clarify whether participants
who said “children” were talking about 2 children or more.
wOne female domestic partner was included in the friends/family with breast cancer because she was a breast cancer survivor.
TABLE 4. Frequency of Influence Types in Different Relationships
Type of
Influence Spouse Children
Spouse and
Children
Family/Friends With
Breast Cancer
Family/Friends: No
Breast Cancer
Health
Professionals Total
Experiential 0 0 0 70 4 2 76
Talk 8 2 10 8 9 2 29
Encouraged CPM 12 5 17 7 10 0 34
Supported my
choice
17 3 20 7 12 3 42
Was supportive 12 4 16 3 7 6 32
Provided
information
0 0 0 4 7 26 37
Decided together 6 0 6 0 1 0 7
Discouraged CPM 0 2 2 1 1 0 4
Total 55 16 67 100 51 39 255
Boldface values were included in the reported 2-way w2 analysis.
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mentioned a range of stories focused on breast cancer topics,
including mammograms, diagnosis, mortality, mastectomy,
and breast reconstruction.
DISCUSSION
Prior research on CPM decisions suggests that the
increase in this procedure is patient driven rather than physi-
cian driven.12–14 The current study provides additional per-
spective on this phenomenon, contributing evidence that
women who chose to pursue CPM elect this surgery, at least in
part, with influence and support from members of their social
networks, including spouses, children, other family, friends, as
well as nonsurgeon health care professionals. Surgeons are
regarded as neutral providers of options, and media influence is
present, but limited.
Most women in this study talked to multiple social net-
work members about their CPM decision, and reported some
degree of influence from those others. Observed differences in
the degree of influence between different relational categories
did not achieve statistical significance, though this may be a
function of sample size. The current data suggest that surgeons
need to anticipate the possibility of meaningful influence on
their patients’ decisions from others who inhabit a variety of
relational roles, ranging from spouses and children to thera-
pists and clergy. These findings suggest a strategy of actively
involving these individuals in the information sharing and
educational portion of the clinic visit. In their commentary on
overtreatment in breast cancer, Katz and Morrow26 state that
the outcomes of the various treatment options being considered
in the examination room must be clarified. Both they and
Angelos et al13 point out that heuristics (gut reactions) and
counterfactual thinking drive patient desire for more extensive
treatment. With patients’ consent, spouses, partners, and
children should be encouraged to attend the discussion of
treatment options. They should be actively engaged in the
conversation and given the opportunity to ask questions, and
ideally transformed from implicit or explicit supporters of
CPM (almost 20% in our sample) to providers of accurate
information about the utility of the procedure. During their
subsequent interactions with the patient, the information these
individuals glean from the clinical encounter may help them
counter the patient’s gut reactions and anticipated regret.
Efforts to educate members of breast cancer patients’
social networks need not be confined to the examination room.
The Pew Research Center’s Internet Project determined as of
January 2014 that a majority of US adults use social net-
working sites such as Facebook. Percentages were 49% for age
65 + , 65% for ages 50 to 64, 82% for ages 30 to 49, and 89%
for ages 18 to 29 (http://www.pewinternet.org/fact-sheets/
social-networking-fact-sheet/). This suggests another strategy
to combat unindicated CPM. Material should be developed that
provide data on the likelihood of a metachronous contralateral
breast cancer, survival as a function of the known cancer,
complications, cost of CPM, and long-term satisfaction/dissat
isfaction of patients who have undergone reconstruction. This
material should be written to address low levels of health and
scientific literacy and be presented in a visually appealing
electronic format. This would provide patients with an oppor
tunity to share evidence-based information with those they will
be consulting with regarding CPM; it would be ideal if this
information were shared across the patients’ social networks so
as to reach and inform much larger audiences than those
accessible through clinical interactions.
The most frequent type of reported influence was expe-
riential, or being influenced by another person’s experience.
This type of influence was exerted principally by friends and
family who had gone through breast cancer, and consisted
largely of reports of cancer recurrence or a new primary breast
cancer, and family history of breast cancer. Thus, although
coded separately from explicit encouragement of CPM, par-
ticipants clearly regarded this type of influence as implicit
support for the CPM choice. Although it is not surprising that
patients sought out family and friends who had gone through
breast cancer and had contemplated similar treatment deci-
sions, the fact that their experiences supported the choice of
CPM should give us pause. Data suggest that regret regarding
treatment decisions for localized breast cancer is low and
relatively stable over time for most patients.27,28 Most friends
and family members diagnosed with breast cancer would have
been treated by breast conservation, and a lesser number by
unilateral mastectomy.29 Given that regret regarding treatment
decisions is low, we would have expected that these individ-
uals would have voiced satisfaction with their treatment
decisions. They may have done so but that is not the message
our respondents heard. Local recurrence is a relatively infre-
quent occurrence,30,31 but the report of this event by the friend
or family member or perhaps an anecdotal report of local
recurrence in someone the friend/family member is acquainted
with seems to have been determinative. This underscores the
challenge of combating powerful individual narratives with
aggregate statistical data.32 Further research is needed to
determine how to accomplish this goal in the context of breast
cancer treatment decisions.
Whereas most of our participants reported social network
influence on their decisions, mass media influence was
reported by a minority. This influence stemmed principally
from television or Internet sources; some participants men-
tioned specific celebrities. Because the CPM decisions
reported in this study took place before the publicity
surrounding Angelina Jolie and Sandra Lee’s “double
mastectomies,” we may have underestimated the current
potential for media influence on CPM decisions. However, the
data to date indicates that the “Jolie Effect” has been mainly to
increase the number of women seeking genetic counseling/
BRCA testing.33,34 In all likelihood, the more powerful influ-
ence is now taking place through social media, where patients
who post about themselves or others choosing CPM combine
the impact of personal endorsement with broad reach into their
own social networks and beyond. This too speaks to the value
of developing accurate and attractive educational materials that
are easy to share electronically.
In free-response descriptions of the surgical consultation,
participants reported few surgeons as either overtly favoring or
opposing CPM, but instead described them as providing
options. Analyzing the ethics of surgeon involvement in the
CPM decision, Angelos et al13 have framed the challenge
facing surgeons as one of respecting patient autonomy versus
abdication of responsibility to avoid doing harm. If the recol-
lections of our respondents are accurate, the surgeons pre-
sented themselves as having no strong opinion for or against
CPM. Although more than half of respondents also reported
that their surgeon “suggested” CPM, it has to be assumed that
this was in the context of listing the treatment options. It is also
unsurprising that participants overwhelmingly reported
“support” for the CPM decision, as few surgeons would con-
tinue expressing lack of support once they had agreed to per-
form CPM. Collectively, these findings suggest that surgeons
need to be more assertive in conveying their perspective.
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As Katz and Morrow26 point out, the responsibility for mini-
mizing overtreatment in breast cancer rests largely in the hands
of the physician. The National Accreditation Program for
Breast Centers 2014 Edition of the Standards Manual states
that centers are compliant when they utilize evidence-based
breast cancer management guidelines such as those of the
NCCN (https://www.facs.org/˜/media/files/quality%20programs/
napbc/2014%20napbc%20standards%20manual.ashx). The NCCN
guidelines clearly discourage CPM unless the patient is 35
years and below or premenopausal and carrier of a known
BRCA1/2 mutation (http://www.nccn.org/professionals/phys
ician_gls/PDF/breast.pdf). Therefore, it is essential that sur
geons are perceived to have an opinion, which is to limit CPM
to where it is appropriate, and that they can clearly articulate
the reasons and evidence for their opinion.
This study exhibits several limitations that should be
taken into account when interpreting our findings and con-
ducting future research. Our sample was limited to women
whose CPM procedures were conducted in a single geographic
region, and who were mostly white. Future research should
continue to examine how factors such as race and socio-
economic status affect CPM decisions. In addition, all of our
interviewees elected CPM, and we report on a decision that
was made as much as 6 years before participation in the study.
Over time, choice-supportive bias35 may have resulted in
diminished memory of interactions that were less positive
toward CPM, skewing participants’ reports in a pro-CPM
direction. Addressing this limitation in our work will likely
require that researchers study women who are in the process of
making their treatment decisions. Comparing women who
strongly considered CPM but ultimately chose breast con-
servation or unilateral mastectomy with those who chose CPM,
Hawley et al36 reported that those who chose CPM were sig-
nificantly more likely to be “very worried about recurrence”
(93.8% vs. 80.1%, P = 0.001). Nevertheless, 4 out of 5 women
who did not choose CPM were still “very worried about
recurrence,” but chose another surgical therapy suggesting
there were additional considerations affecting their decisions.
To guide surgeon’s consultations, future research should also
examine why women decide against CPM, who influences
them, and especially how women who initially wanted CPM
are dissuaded (ethically and compassionately) from pursuing
this path.
Identifying the individuals who exert the greatest influ-
ence and the type of influence they exert provides an additional
opportunity for medical professionals, in general, and sur-
geons, in particular, to dampen and reverse the increase in
CPM. These individuals can be partners in this endeavor by
reinforcing the information provided to the patient. From a
surgeon’s perspective, it would be far preferable to use infor-
mation, social networks, and social media to reduce CPMs
rather than having the same result imposed by payers.
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